Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joaquin Bellmunt Molins, M.D.

Concepts (679)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urologic Neoplasms62201931617.410 Why?
Carcinoma, Transitional Cell87202180215.500 Why?
Urinary Bladder Neoplasms1332020223714.880 Why?
Urothelium3620212777.560 Why?
Antineoplastic Combined Chemotherapy Protocols1212021114936.060 Why?
Carcinoma, Renal Cell65201831305.640 Why?
Kidney Neoplasms70201842455.640 Why?
Antineoplastic Agents992021136684.460 Why?
Cisplatin46202116424.120 Why?
Vinblastine2520194903.690 Why?
Taxoids2920196653.540 Why?
Cystectomy3220196863.490 Why?
Salvage Therapy16201812752.730 Why?
Deoxycytidine2520198252.460 Why?
Molecular Targeted Therapy19201927272.410 Why?
Carcinoma20201823752.320 Why?
Benzenesulfonates1220101692.270 Why?
Pyrroles17201411432.210 Why?
Antibodies, Monoclonal29202192752.170 Why?
Neoplasm Metastasis48201948412.080 Why?
Disease-Free Survival59202168931.970 Why?
Indoles17201418381.940 Why?
Immunotherapy20202144401.940 Why?
Nomograms620182281.940 Why?
Prostatic Neoplasms442019110741.900 Why?
Angiogenesis Inhibitors17201720381.660 Why?
Ureteral Neoplasms520161101.600 Why?
Survival Analysis552019102501.580 Why?
Pyridines15201928221.570 Why?
Paclitaxel15201917071.530 Why?
Organoplatinum Compounds720174081.520 Why?
Chemotherapy, Adjuvant28201834741.450 Why?
Urogenital Neoplasms420151351.350 Why?
Protein Kinase Inhibitors18201655291.320 Why?
Neoadjuvant Therapy22201927261.230 Why?
Prognosis622019290501.200 Why?
Endonucleases420173811.190 Why?
Neoplasm Invasiveness27202136141.190 Why?
Humans39720217442201.180 Why?
Carboplatin1720198001.170 Why?
Niacinamide1620144161.120 Why?
Phenylthiohydantoin620161921.110 Why?
Platinum720182331.090 Why?
Treatment Outcome1132018631191.090 Why?
Imidazoles7201912061.080 Why?
Clinical Trials, Phase II as Topic1420186281.060 Why?
Neoplasm Staging402018110071.050 Why?
Phenylurea Compounds1620145271.040 Why?
Bone Neoplasms13201825250.990 Why?
Male23520213500270.980 Why?
Muscles5202116220.950 Why?
Antineoplastic Agents, Hormonal9201615090.940 Why?
Aged16720211632530.930 Why?
Orchiectomy920154660.920 Why?
Prostate-Specific Antigen18201924780.880 Why?
TOR Serine-Threonine Kinases9201621080.880 Why?
Androgen Receptor Antagonists520161140.870 Why?
Neoplasm Recurrence, Local23202092300.820 Why?
Androgen Antagonists15201813610.820 Why?
Vascular Endothelial Growth Factor A12201835060.810 Why?
Sirolimus9201415630.790 Why?
Survival Rate312019127810.790 Why?
Gene Expression Regulation, Neoplastic14201984260.790 Why?
Middle Aged16320212133670.780 Why?
Adenocarcinoma15201863520.780 Why?
Prostatectomy10201718870.780 Why?
Platinum Compounds62018960.770 Why?
Drug Administration Schedule25201849290.760 Why?
Kaplan-Meier Estimate28201865350.750 Why?
Watchful Waiting520184910.750 Why?
Aged, 80 and over762019577680.730 Why?
Pyrimidines6201929400.720 Why?
Antineoplastic Agents, Phytogenic420136230.720 Why?
Indazoles420182870.710 Why?
Muscle Neoplasms420181390.700 Why?
Clinical Trials, Phase III as Topic1520158400.670 Why?
Female17020213801970.660 Why?
Benzoxazoles12019770.650 Why?
Combined Modality Therapy22201986280.640 Why?
Urology420173990.610 Why?
Fluorouracil8201416160.610 Why?
Radium32018650.600 Why?
Cancer Vaccines4201410240.600 Why?
DNA Copy Number Variations6201819400.590 Why?
Radiotherapy7201715250.580 Why?
Morpholines220195730.570 Why?
Cytosine Deaminase12016680.550 Why?
Societies, Medical8201937410.550 Why?
Methotrexate18201517200.530 Why?
Clinical Trials as Topic24201879080.530 Why?
Gene Dosage3202012510.530 Why?
Fanconi Anemia Complementation Group Proteins120151000.530 Why?
Perioperative Care4201510000.520 Why?
Health Planning Guidelines320141630.520 Why?
BCG Vaccine420183680.520 Why?
Radiopharmaceuticals4201426620.520 Why?
Neovascularization, Pathologic7201626360.520 Why?
Prednisone7201715750.520 Why?
Follow-Up Studies322020390450.510 Why?
Randomized Controlled Trials as Topic21201999600.500 Why?
Disease Progression252018132800.500 Why?
Drug Resistance, Neoplasm17201751690.500 Why?
Infusions, Intravenous9201722720.500 Why?
Mutation202020297840.500 Why?
DNA-Binding Proteins6201996470.490 Why?
Xeroderma Pigmentosum Group D Protein320201050.480 Why?
Anilides320154050.470 Why?
Carcinoma in Situ320178050.460 Why?
Kallikreins320162580.440 Why?
Dose-Response Relationship, Drug142019109490.440 Why?
Alpha Particles12012260.440 Why?
Lymphocytes, Tumor-Infiltrating2201710390.440 Why?
Spain920154650.430 Why?
Adult9420212140350.430 Why?
Lymph Node Excision8201712560.430 Why?
Receptor Protein-Tyrosine Kinases4201616600.430 Why?
Patient-Centered Care3201214380.420 Why?
Interferon-alpha920138950.420 Why?
Gene Expression Profiling8201894380.420 Why?
Serum Albumin120156760.420 Why?
Sulfonamides3201819400.410 Why?
Drugs, Investigational220112140.410 Why?
Gonadotropin-Releasing Hormone4201811870.410 Why?
Receptor, erbB-24201624160.400 Why?
Fluorine Radioisotopes120144490.390 Why?
High-Throughput Nucleotide Sequencing4201835980.390 Why?
Ifosfamide319982280.380 Why?
Designer Drugs12010200.380 Why?
Hyponatremia120132980.380 Why?
Muscle, Smooth520179340.370 Why?
Doxorubicin11201522200.360 Why?
Benzamides7201813780.360 Why?
Maximum Tolerated Dose520178920.360 Why?
Europe12201733390.360 Why?
Proportional Hazards Models182017123550.360 Why?
Quality of Life122018128050.360 Why?
Urinary Bladder6201811720.360 Why?
Genomics6201857220.360 Why?
Practice Guidelines as Topic11201872810.350 Why?
Granulocyte Colony-Stimulating Factor520146480.350 Why?
Rectum120149040.350 Why?
Lymphatic Metastasis11201729140.350 Why?
Carbon Radioisotopes120105920.340 Why?
Immunotherapy, Active12009600.330 Why?
Hemoglobins2201715330.330 Why?
Liver Neoplasms10201742520.330 Why?
Nitriles820169520.330 Why?
Fluorodeoxyglucose F182201420170.330 Why?
Drug Carriers120136930.320 Why?
Stomach Neoplasms4201213330.320 Why?
Retrospective Studies382019774260.320 Why?
Methionine120105900.320 Why?
Sodium1201316230.320 Why?
Interleukin-8120116900.310 Why?
HSP27 Heat-Shock Proteins22018700.310 Why?
Neutropenia520178950.310 Why?
Tubulin Modulators120081100.310 Why?
Tetrahydroisoquinolines32014910.300 Why?
Predictive Value of Tests132018150700.300 Why?
Sarcoma4201118970.300 Why?
Thromboembolism220129850.300 Why?
Receptors, Vascular Endothelial Growth Factor420136640.300 Why?
Positron-Emission Tomography3201462740.290 Why?
Soft Tissue Neoplasms3201013630.290 Why?
Administration, Oral9201939130.290 Why?
Palliative Care5201234900.280 Why?
Proto-Oncogene Proteins c-akt1201525030.280 Why?
Cyclin-Dependent Kinase Inhibitor p16220207040.280 Why?
Colon1201417720.280 Why?
Receptor, Fibroblast Growth Factor, Type 3220181050.280 Why?
Drug Delivery Systems2201622180.270 Why?
Prospective Studies212018532800.270 Why?
MicroRNAs4201737470.270 Why?
Patient Selection9201942160.270 Why?
Nephrectomy8201710490.270 Why?
Medical Oncology4201822650.260 Why?
Arterial Occlusive Diseases120107930.260 Why?
Biological Products120148600.260 Why?
Antimetabolites, Antineoplastic420096400.260 Why?
Phosphatidylinositol 3-Kinases1201529380.260 Why?
Neoplasm Proteins3201537030.250 Why?
Alkyl and Aryl Transferases12005890.250 Why?
Antineoplastic Agents, Alkylating320116270.250 Why?
Colorectal Neoplasms7201667730.240 Why?
Nails319912910.240 Why?
Lung Neoplasms142015130960.240 Why?
Time Factors272018400630.240 Why?
DNA Repair3201820460.230 Why?
Protective Agents220141560.230 Why?
Administration, Intravesical32018910.220 Why?
Double-Blind Method112017120350.220 Why?
Treatment Failure5201326190.220 Why?
Molecular Chaperones320187420.220 Why?
Signal Transduction82016234040.220 Why?
Risk Assessment142018233370.220 Why?
Drug Evaluation, Preclinical3201813720.220 Why?
Comparative Genomic Hybridization220144960.210 Why?
Thalidomide320178900.210 Why?
Gene Expression Regulation, Enzymologic1200712130.200 Why?
Tegafur31998490.200 Why?
Xenograft Model Antitumor Assays3201935570.200 Why?
Bone Remodeling320185750.200 Why?
Adjuvants, Immunologic1200710010.200 Why?
Nanoparticles1201319050.200 Why?
Drug Synergism3201917910.200 Why?
Leucovorin419986240.200 Why?
Immunosuppressive Agents2201241510.200 Why?
Tumor Suppressor Protein p534202029480.200 Why?
Risk Factors222018722800.190 Why?
Cell Line, Tumor92019166870.190 Why?
Italy220138320.190 Why?
Colonic Neoplasms1201325380.190 Why?
Urinary Diversion220181370.190 Why?
Dioxoles220111040.190 Why?
RNA, Messenger72016130360.190 Why?
In Situ Hybridization, Fluorescence4201526490.190 Why?
Cholangiocarcinoma120065160.190 Why?
Vinca Alkaloids22011340.190 Why?
Brachytherapy3201712460.190 Why?
Bleomycin319915010.190 Why?
Alkaline Phosphatase220138650.190 Why?
Drug Therapy220144970.180 Why?
Cohort Studies162018405590.180 Why?
Breast Neoplasms162011208170.180 Why?
Lymph Nodes5201734690.180 Why?
Carcinoma, Squamous Cell7201440330.180 Why?
Cyclin E120201720.180 Why?
Patient Care Team2200825290.180 Why?
Animals1920191687880.170 Why?
Hemangioendothelioma219901210.170 Why?
Breast Neoplasms, Male219982100.170 Why?
Genetic Variation1201465460.170 Why?